Santosh Vetticaden - Net Worth and Insider Trading
Santosh Vetticaden Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Santosh Vetticaden owns 2 companies in total, including Insys Therapeutics Inc (INSYQ) , and Savara Inc (SVRA) .
Click here to see the complete history of Santosh Vetticaden’s form 4 insider trades.
Insider Ownership Summary of Santosh Vetticaden
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INSYQ | Insys Therapeutics Inc | 2017-02-21 | Interim CEO and CMO |
SVRA | Savara Inc | 2012-09-05 | Chief Medical Officer & SVP |
Santosh Vetticaden Trading Performance
Santosh Vetticaden Ownership Network
Ownership Network List of Santosh Vetticaden
Ownership Network Relation of Santosh Vetticaden
Santosh Vetticaden Owned Company Details
What does Insys Therapeutics Inc do?
Who are the key executives at Insys Therapeutics Inc?
Santosh Vetticaden is the Interim CEO and CMO of Insys Therapeutics Inc. Other key executives at Insys Therapeutics Inc include director & Chief Executive Officer Andrew G Long , Chief Legal Officer & Gen Cnsl Mark E Nance , and 10 percent owner John N Kapoor .
Insys Therapeutics Inc (INSYQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Insys Therapeutics Inc (INSYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Insys Therapeutics Inc (INSYQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Insys Therapeutics Inc (INSYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Insys Therapeutics Inc Insider Transactions
Santosh Vetticaden Mailing Address
Above is the net worth, insider trading, and ownership report for Santosh Vetticaden. You might contact Santosh Vetticaden via mailing address: C/o Adventrx Pharmaceuticals, Inc., 12390 El Camino Real, Suite 150, San Diego Ca 92130.